Evidence map›Paper›PMID 36467721›Full record

ArticleFrontiers in cellular and infection microbiology2022

Bacteriophage-based decontamination to control environmental colonization by

Marie Chavignon, Camille Kolenda, Mathieu Medina, Mélanie Bonhomme, Leslie Blazere, Tiphaine Legendre, Anne Tristan, Frédéric Laurent, Marine Butin

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Isolation and characterization of a novelFrontiers in cellular and infection microbiology · 2026
    Article
  3. Article
  4. Environmental hygiene strategies to combat antimicrobial resistance in healthcare settings.Antimicrobial stewardship & healthcare epidemiology : ASHE · 2025
    Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 1 country.

Marie ChavignonCentre International de Recherche en Infectiologie (CIRI), Team « Pathogénie des Staphylocoques », Inserm, U1111, Centre national de la recherche scientifique (CNRS) UMR5308, Ecole normale supérieure (ENS) Lyon, Université Claude Bernard Lyon 1, Lyon, France.
Camille KolendaCentre International de Recherche en Infectiologie (CIRI), Team « Pathogénie des Staphylocoques », Inserm, U1111, Centre national de la recherche scientifique (CNRS) UMR5308, Ecole normale supérieure (ENS) Lyon, Université Claude Bernard Lyon 1, Lyon, France.
Mathieu MedinaCentre International de Recherche en Infectiologie (CIRI), Team « Pathogénie des Staphylocoques », Inserm, U1111, Centre national de la recherche scientifique (CNRS) UMR5308, Ecole normale supérieure (ENS) Lyon, Université Claude Bernard Lyon 1, Lyon, France.
Mélanie BonhommeCentre International de Recherche en Infectiologie (CIRI), Team « Pathogénie des Staphylocoques », Inserm, U1111, Centre national de la recherche scientifique (CNRS) UMR5308, Ecole normale supérieure (ENS) Lyon, Université Claude Bernard Lyon 1, Lyon, France.
Leslie BlazereCentre International de Recherche en Infectiologie (CIRI), Team « Pathogénie des Staphylocoques », Inserm, U1111, Centre national de la recherche scientifique (CNRS) UMR5308, Ecole normale supérieure (ENS) Lyon, Université Claude Bernard Lyon 1, Lyon, France.
Tiphaine LegendreCentre International de Recherche en Infectiologie (CIRI), Team « Pathogénie des Staphylocoques », Inserm, U1111, Centre national de la recherche scientifique (CNRS) UMR5308, Ecole normale supérieure (ENS) Lyon, Université Claude Bernard Lyon 1, Lyon, France.
Anne TristanCentre International de Recherche en Infectiologie (CIRI), Team « Pathogénie des Staphylocoques », Inserm, U1111, Centre national de la recherche scientifique (CNRS) UMR5308, Ecole normale supérieure (ENS) Lyon, Université Claude Bernard Lyon 1, Lyon, France.
Frédéric LaurentCentre International de Recherche en Infectiologie (CIRI), Team « Pathogénie des Staphylocoques », Inserm, U1111, Centre national de la recherche scientifique (CNRS) UMR5308, Ecole normale supérieure (ENS) Lyon, Université Claude Bernard Lyon 1, Lyon, France.
Marine ButinCentre International de Recherche en Infectiologie (CIRI), Team « Pathogénie des Staphylocoques », Inserm, U1111, Centre national de la recherche scientifique (CNRS) UMR5308, Ecole normale supérieure (ENS) Lyon, Université Claude Bernard Lyon 1, Lyon, France.
Centre International de Recherche en Infectiologie · FRÉcole Normale Supérieure de Lyon · FRCentre National de la Recherche Scientifique · FRHospices Civils de Lyon · FRInserm · FRUniversité Claude Bernard Lyon 1 · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: In neonatal intensive care units (NICUs), the standard chemical-based disinfection procedures do not allow a complete eradication of pathogens from environmental surfaces. In particular, the clone Methods: Three bacteriophages were isolated, genetically characterized and assessed for their host range using a collection of representative clinical strains (n=31) belonging to the clone NRCS-A. The efficacy of a cocktail including these three bacteriophages to eradicate the reference strain Results: The three bacteriophages belonged to two families and genera, namely Discussion: This study established a proof-of-concept for the use of bacteriophages to fight against

Indexed as

BacteriophagesStaphylococcus capitisDecontaminationHost SpecificityHumansInfant, NewbornIntensive Care Units, Neonatalbacteriophagesbiofilmdisinfectionneonatal intensive care units (NICU)staphylococcus capitis NRCS-A

Identifiers

PMID36467721
PMCPMC9710537
OpenAlexW4309308656

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.